Related Experiment Video
Updated: Feb 23, 2026
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Undescribed and nephroprotective diterpenoids from Daphne genkwa
Hong-Bo Ye1, Xian-Run Wu2, Li Wang2
1Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education and Yunnan Province, School of Institute of International Rivers and Eco-security, School of Chemical Science and Technology, Yunnan University, Kunming, 650500, China; Southwest United Graduate School, Kunming 650092, China.
New diterpenoids from Daphne genkwa buds, daphngenoids A-B, show potential in combating doxorubicin-induced inflammation and oxidative stress in kidney cells.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Daphne genkwa buds are a source of bioactive compounds.
- Doxorubicin can induce inflammation and oxidative stress in kidney cells.
Purpose of the Study:
- To isolate and characterize new diterpenoids from Daphne genkwa buds.
- To evaluate the anti-inflammatory and antioxidant effects of isolated compounds.
Main Methods:
- Isolation and structural elucidation of compounds using chromatographic and spectroscopic techniques.
- In vitro assays using human kidney proximal tubular epithelial cells (HK-2) to assess inflammation and oxidative stress.
Main Results:
- Three new diterpenoids, daphngenoids A-C, were identified, along with eight known compounds.
- Daphngenoids A-B demonstrated significant inhibition of doxorubicin-induced inflammation and oxidative stress in HK-2 cells.
Conclusions:
- Daphne genkwa buds contain novel lathyrane and daphnane-type diterpenoids.
- Daphngenoids A-B possess promising anti-inflammatory and antioxidant properties, suggesting therapeutic potential for kidney protection.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
